Companies in #Orphan Therapeutics

Keenova is the specialty therapeutics subsidiary formed to commercialize Xiaflex (collagenase clostridium histolyticum) for Dupuytren's contracture and Peyronie's disease following Endo International's bankruptcy-related restructuring.